Cargando…
Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
Astrocytomas are the most common subtype of brain tumors and no curative treatment exist. Longitudinal assessment of patients, usually via Magnetic Resonance Imaging (MRI), is crucial since tumor progression may occur earlier than clinical progression. MRI usually provides a means for monitoring the...
Autores principales: | Ruiz-Rodado, Victor, Dowdy, Tyrone, Lita, Adrian, Kramp, Tamalee, Zhang, Meili, Shuboni-Mulligan, Dorela, Herold-Mende, Christel, Armstrong, Terri S., Gilbert, Mark R., Camphausen, Kevin, Larion, Mioara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638021/ https://www.ncbi.nlm.nih.gov/pubmed/36353533 http://dx.doi.org/10.3389/fonc.2022.979537 |
Ejemplares similares
-
Cysteine is a limiting factor for glioma proliferation and survival
por: Ruiz‐Rodado, Victor, et al.
Publicado: (2022) -
DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021) -
Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma
por: Ruiz-Rodado, Victor, et al.
Publicado: (2020) -
BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS
por: Yamasaki, Tomohiro, et al.
Publicado: (2021) -
Sphingolipid Pathway as a Source of Vulnerability in IDH1(mut) Glioma
por: Dowdy, Tyrone, et al.
Publicado: (2020)